HEALTH● LOW1h ago · Oct 14, 2026, 3:57 PM
ImmunityBio's Anktiva gains expanded bladder cancer approval
Seeking Alpha Tech · global
ImmunityBio's drug Anktiva has received expanded approval for bladder cancer, signifying a new development in cancer treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH43m agoSecond Ebola case confirmed in KenyaThe TelegraphHEALTH44m agoSenate Republican knocks Trump administration on measles surge: ‘Get vaccinated, you don’t die’The HillHEALTH1h agoKenya confirms second Ebola case as relative of country's first victimBBC WorldHEALTH1h agoPope Leo recovers well after cancer surgery, can eat againNOS Buitenland